Cushing's Syndrome and Fetal Features Resurgence in Adrenal Cortex–Specific Knockout Mice

English version České info

Carney complex (CNC) is an inherited neoplasia syndrome with endocrine overactivity. Its most frequent endocrine manifestation is primary pigmented nodular adrenocortical disease (PPNAD), a bilateral adrenocortical hyperplasia causing pituitary-independent Cushing's syndrome. Inactivating mutations in PRKAR1A, a gene encoding the type 1 α-regulatory subunit (R1α) of the cAMP–dependent protein kinase (PKA) have been found in 80% of CNC patients with Cushing's syndrome. To demonstrate the implication of R1α loss in the initiation and development of PPNAD, we generated mice lacking Prkar1a specifically in the adrenal cortex (AdKO). AdKO mice develop pituitary-independent Cushing's syndrome with increased PKA activity. This leads to autonomous steroidogenic genes expression and deregulated adreno-cortical cells differentiation, increased proliferation and resistance to apoptosis. Unexpectedly, R1α loss results in improper maintenance and centrifugal expansion of cortisol-producing fetal adrenocortical cells with concomitant regression of adult cortex. Our data provide the first in vivo evidence that loss of R1α is sufficient to induce autonomous adrenal hyper-activity and bilateral hyperplasia, both observed in human PPNAD. Furthermore, this model demonstrates that deregulated PKA activity favors the emergence of a new cell population potentially arising from the fetal adrenal, giving new insight into the mechanisms leading to PPNAD.

Vyšlo v časopise: Cushing's Syndrome and Fetal Features Resurgence in Adrenal Cortex–Specific Knockout Mice. PLoS Genet 6(6): e32767. doi:10.1371/journal.pgen.1000980
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000980

Souhrn

Zdroje

1. CarneyJA

GordonH

CarpenterPC

ShenoyBV

GoVL

1985 The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64 270 283

2. KirschnerLS

CarneyJA

PackSD

TaymansSE

GiatzakisC

2000 Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26 89 92

3. CaseyM

VaughanCJ

HeJ

HatcherCJ

WinterJM

2000 Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 106 R31 38

4. GroussinL

JullianE

PerlemoineK

LouvelA

LeheupB

2002 Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 87 4324 4329

5. AmieuxPS

HoweDG

KnickerbockerH

LeeDC

SuT

2002 Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. J Biol Chem 277 27294 27304

6. KirschnerLS

KusewittDF

MatyakhinaL

TownsWH2nd

CarneyJA

2005 A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res 65 4506 4514

7. VeugelersM

WilkesD

BurtonK

McDermottDA

SongY

2004 Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A 101 14222 14227

8. GriffinKJ

KirschnerLS

MatyakhinaL

StergiopoulosSG

Robinson-WhiteA

2004 A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J Med Genet 41 923 931

9. YinZ

JonesGN

TownsWH2nd

ZhangX

AbelED

2008 Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. Circulation 117 1414 1422

10. YinZ

Williams-SimonsL

ParlowAF

AsaS

KirschnerLS

2008 Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 22 380 387

11. JonesGN

TepC

TownsWH2nd

MihaiG

TonksID

2008 Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production. Neoplasia 10 1213 1221

12. BertheratJ

HorvathA

GroussinL

GrabarS

BoikosS

2009 Mutations in regulatory subunit type 1A of cyclic AMP-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab

13. Lambert-LanglaisS

ValP

GuyotS

RagazzonB

Sahut-BarnolaI

2009 A transgenic mouse line with specific Cre recombinase expression in the adrenal cortex. Mol Cell Endocrinol 300 197 204

14. KimAC

HammerGD

2007 Adrenocortical cells with stem/progenitor cell properties: recent advances. Mol Cell Endocrinol 265-266 10 16

15. ParviainenH

KiiveriS

BielinskaM

RahmanN

HuhtaniemiIT

2007 GATA transcription factors in adrenal development and tumors. Mol Cell Endocrinol 265-266 17 22

16. KingP

PaulA

LauferE

2009 Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc Natl Acad Sci U S A 106 21185 21190

17. KimAC

BarlaskarFM

HeatonJH

ElseT

KellyVR

2009 In search of adrenocortical stem and progenitor cells. Endocr Rev 30 241 263

18. KimAC

ReuterAL

ZubairM

ElseT

SereckyK

2008 Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 135 2593 2602

19. ThomasM

KeramidasM

MonchauxE

FeigeJJ

2004 Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex. Endocrinology 145 4320 4329

20. SpencerSJ

MesianoS

LeeJY

JaffeRB

1999 Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. J Clin Endocrinol Metab 84 1110 1115

21. BeuschleinF

LooyengaBD

BleasdaleSE

MutchC

BaversDL

2003 Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol Cell Biol 23 3951 3964

22. ChenYG

LuiHM

LinSL

LeeJM

YingSY

2002 Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 227 75 87

23. HolmesPV

DicksonAD

1971 X-zone degeneration in the adrenal glands of adult and immature female mice. J Anat 108 159 168

24. ZubairM

ParkerKL

MorohashiK

2008 Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol Cell Biol 28 7030 7040

25. AigueperseC

MartinezA

Lefrancois-MartinezAM

VeyssiereG

JeanCI

1999 Cyclic AMP regulates expression of the gene coding for a mouse vas deferens protein related to the aldo-keto reductase superfamily in human and murine adrenocortical cells. J Endocrinol 160 147 154

26. HershkovitzL

BeuschleinF

KlammerS

KrupM

WeinsteinY

2007 Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. Endocrinology 148 976 988

27. KeeneyDS

JenkinsCM

WatermanMR

1995 Developmentally regulated expression of adrenal 17 alpha-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136 4872 4879

28. Gomez MuguruzaMT

ChrousosGP

1989 Periodic Cushing syndrome in a short boy: usefulness of the ovine corticotropin releasing hormone test. J Pediatr 115 270 273

29. SarlisNJ

ChrousosGP

DoppmanJL

CarneyJA

StratakisCA

1997 Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 82 1274 1278

30. StratakisCA

SarlisN

KirschnerLS

CarneyJA

DoppmanJL

1999 Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 131 585 591

31. BourdeauI

LacroixA

SchurchW

CaronP

AntaklyT

2003 Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J Clin Endocrinol Metab 88 3931 3937

32. LouisetE

StratakisCA

PerraudinV

GriffinKJ

LibeR

2009 The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. J Clin Endocrinol Metab 94 2406 2413

33. ShenoyBV

CarpenterPC

CarneyJA

1984 Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol 8 335 344

34. BrunkUT

TermanA

2002 Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 33 611 619

35. MavrakisM

Lippincott-SchwartzJ

StratakisCA

BossisI

2006 Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency. Hum Mol Genet 15 2962 2971

36. KurzT

TermanA

BrunkUT

2007 Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch Biochem Biophys 462 220 230

37. MavrakisM

Lippincott-SchwartzJ

StratakisCA

BossisI

2007 mTOR kinase and the regulatory subunit of protein kinase A (PRKAR1A) spatially and functionally interact during autophagosome maturation. Autophagy 3 151 153

38. RuvinskyI

MeyuhasO

2006 Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31 342 348

39. TaylorSS

BuechlerJA

YonemotoW

1990 cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 59 971 1005

40. NadellaKS

KirschnerLS

2005 Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res 65 10307 10315

41. HorvathA

MathyakinaL

VongQ

BaxendaleV

PangAL

2006 Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. J Clin Endocrinol Metab 91 584 596

42. IseliBE

HedingerCE

1985 Histopathology and ultrastructure of primary adrenocortical nodular dysplasia with Cushing's syndrome. Histopathology 9 1171 1194

43. AibaM

HirayamaA

IriH

KodamaT

FujimotoY

1990 Primary adrenocortical micronodular dysplasia: enzyme histochemical and ultrastructural studies of two cases with a review of the literature. Hum Pathol 21 503 511

44. ZubairM

IshiharaS

OkaS

OkumuraK

MorohashiK

2006 Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1. Mol Cell Biol 26 4111 4121

45. VoutilainenR

EramaaM

RitvosO

1991 Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J Clin Endocrinol Metab 73 1026 1030

46. RagazzonB

CazabatL

Rizk-RabinM

AssieG

GroussinL

2009 Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells. Cancer Res 69 7278 7284

47. SpencerSJ

RabinoviciJ

MesianoS

GoldsmithPC

JaffeRB

1992 Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. J Clin Invest 90 142 149

48. ItoM

ParkY

WeckJ

MayoKE

JamesonJL

2000 Synergistic activation of the inhibin alpha-promoter by steroidogenic factor-1 and cyclic adenosine 3',5'-monophosphate. Mol Endocrinol 14 66 81

49. VanttinenT

KuulasmaaT

LiuJ

VoutilainenR

2002 Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. J Clin Endocrinol Metab 87 4257 4263

50. KananenK

MarkkulaM

MikolaM

RainioEM

McNeillyA

1996 Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene. Mol Endocrinol 10 1667 1677

51. FarnworthPG

StantonPG

WangY

EscalonaR

FindlayJK

2006 Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line. Endocrinology 147 3462 3471

52. GrumbachMM

BillerBM

BraunsteinGD

CampbellKK

CarneyJA

2003 Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138 424 429

53. HeikkilaM

PeltoketoH

LeppaluotoJ

IlvesM

VuolteenahoO

2002 Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143 4358 4365

54. BelloniAS

MazzocchiG

MeneghelliV

NussdorferGG

1978 Cytogenesis in the rat adrenal cortex: evidence for an ACTH-induced centripetal cell migration from the zona glomerulosa. Arch Anat Histol Embryol 61 195 205

55. DoghmanM

KarpovaT

RodriguesGA

ArhatteM

De MouraJ

2007 Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 21 2968 2987

56. BerthonA

Sahut-BarnolaI

Lambert-LanglaisS

de JoussineauC

Damon-SoubeyrandC

2010 Constitutive {beta}-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum Mol Genet

57. LooyengaBD

WiaterE

ValeW

HammerGD

2010 Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan. Mol Endocrinol 24 608 620

58. LiuJ

MatyakhinaL

HanZ

SandriniF

BeiT

2003 Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues. Faseb J 17 1189 1191

59. Lefrancois-MartinezAM

BertheratJ

ValP

TournaireC

Gallo-PayetN

2004 Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. J Clin Endocrinol Metab 89 3010 3019

60. RagazzonB

Lefrancois-MartinezAM

ValP

Sahut-BarnolaI

TournaireC

2006 Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis. Endocrinology 147 1805 1818

61. GroussinL

HorvathA

JullianE

BoikosS

Rene-CorailF

2006 A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 91 1943 1949